Skip to search boxSkip to navigationSkip to main content

Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season

  • Jesús Castilla(corresponding author)
    ,
  • A. Navascués
    ,
  • M. Fernández-Alonso
    ,
  • G. Reina
    ,
  • E. Albéniz
    ,
  • F. Pozo
*Corresponding author for this work
  • Instituto de Salud Pública de Navarra
    ,
  • Navarre Institute for Health Research
    ,
  • World Health Organization
    ,
  • Servicio Navarro de Salud
    ,
  • Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)
    ,
Research Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

We estimated whether previous episodes of influenza and trivalent influenza vaccination prevented laboratory- confirmed influenza in Navarre, Spain, in season 2013/14. Patients with medically-attended influenzalike illness (MA-ILI) in hospitals (n = 645) and primary healthcare (n = 525) were included. We compared 589 influenza cases and 581 negative controls. MA-ILI related to a specific virus subtype in the previous five seasons was defined as a laboratory-confirmed influenza infection with the same virus subtype or MA-ILI during weeks when more than 25% of swabs were positive for this subtype. Persons with previous MA-ILI had 30% (95% confidence interval (CI): −7 to 54) lower risk of MA-ILI, and those with previous MA-ILI related to A(H1N1)pdm09 or A(H3N2) virus, had a, respectively, 63% (95% CI: 16–84) and 65% (95% CI: 13–86) lower risk of new laboratory-confirmed influenza by the same subtype. Overall adjusted vaccine effectiveness in preventing laboratory-confirmed influenza was 31% (95% CI: 5–50): 45% (95% CI: 12–65) for A(H1N1) pdm09 and 20% (95% CI: −16 to 44) for A(H3N2). While a previous influenza episode induced high protection only against the same virus subtype, influenza vaccination provided low to moderate protection against all circulating subtypes. Influenza vaccine remains the main preventive option for high-risk populations.

Research Output Information

Output type

Research Output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1-10 (10 pages)

Journal (Volume, Issue Number)

Eurosurveillance (Volume 21, Issue 22)

Publication milestones

  • Published - 02/06/2016

Publication status

Published - 02/06/2016

ISSN

1025-496X

Publication IDs

  • Scopus: 85014122818
  • PubMed: 27277013

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Metrics

SciVal
FWCI
1.32
SciVal
Author count
115
SciVal
Paper percentile
78
SciVal
citations
18
Scopus
citations
Download statistics
Download count
1

PlumX, opens in new tab

Captures
32
Mentions
1
Citation count
21